We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
Teladoc (TDOC - Free Report) closed at $5.69 in the latest trading session, marking a -2.23% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.2%. At the same time, the Dow added 1.79%, and the tech-heavy Nasdaq gained 1.52%.
The stock of telehealth services provider has risen by 5.43% in the past month, leading the Medical sector's loss of 2.77% and the S&P 500's gain of 5.15%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 29, 2026. The company's earnings per share (EPS) are projected to be -$0.32, reflecting a 68.42% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $612.3 million, down 2.71% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$0.89 per share and a revenue of $2.51 billion, indicating changes of +21.93% and -0.81%, respectively, from the former year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Teladoc. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Teladoc is currently sporting a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 89, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
Teladoc (TDOC - Free Report) closed at $5.69 in the latest trading session, marking a -2.23% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.2%. At the same time, the Dow added 1.79%, and the tech-heavy Nasdaq gained 1.52%.
The stock of telehealth services provider has risen by 5.43% in the past month, leading the Medical sector's loss of 2.77% and the S&P 500's gain of 5.15%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 29, 2026. The company's earnings per share (EPS) are projected to be -$0.32, reflecting a 68.42% decrease from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $612.3 million, down 2.71% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$0.89 per share and a revenue of $2.51 billion, indicating changes of +21.93% and -0.81%, respectively, from the former year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Teladoc. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Teladoc is currently sporting a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 89, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.